PEGDA microencapsulated allogeneic islets reverse canine diabetes without immunosuppression.

<h4>Background</h4>Protection of islets without systemic immunosuppression has been a long-sought goal in the islet transplant field. We conducted a pilot biocompatibility/safety study in healthy dogs followed by a dose-finding efficacy study in diabetic dogs using polyethylene glycol diacrylate (PE...

Descripció completa

Dades bibliogràfiques

Autors principals:	Stephen Harrington, Francis Karanu, Karthik Ramachandran, S Janette Williams, Lisa Stehno-Bittel
Format:	Artigo
Idioma:	Inglês
Publicat:	Public Library of Science (PLoS) 2022-01-01
Col·lecció:	PLoS ONE
Accés en línia:	https://doi.org/10.1371/journal.pone.0267814
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!